MODIFICATION
66 -- Preventative Maintenance of Q-Sense E4 Quartz Crystal Microbalance Equipment
- Notice Date
- 4/25/2013
- Notice Type
- Modification/Amendment
- NAICS
- 541712
— Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001
- ZIP Code
- 20857-0001
- Solicitation Number
- FDA-13-SOL-113656
- Archive Date
- 5/3/2013
- Point of Contact
- Joy Garnett, Phone: 3018270469
- E-Mail Address
-
joy.garnett@fda.hhs.gov
(joy.garnett@fda.hhs.gov)
- Small Business Set-Aside
- Total Small Business
- Description
- Pursuant to Federal Acquisition Regulation (FAR)Subparts 6.302-1 and 5.207, this is a notice of intent to award a firm-fixed price purchase order for preventative maintenance of the U.S. Food and Drug Administration's Q-Sense E4 quartz crystal microbalance laboratory equipment to Biolin Scientific, Inc. for $47,460.00 in accordance with the attached Statement of Work. Award will be made in accordance with FAR Subpart 6.302-1, only one responsible source and no other supplies or services will satisfy agency requirements using Simplified Acquisition Procedures per FAR Part 13. This requirement is being awarded to Biolin Scientific, Inc. on the following basis: (1) Q-Sense is the sole provider of the quartz crystal microbalance with dissipation (QCM-D) technology, (2) Biolin Scientific is the owner of the Q-Sense brand, and (3) Biolin Scientific is the only company that is certified to perform maintenance work on QCM-D systems. The period of performance shall be for a base period of one (1) year, with four (4), one (1) year option periods from the date of award. The place of performance will be at FDA's facility, which is located at 10903 New Hampshire Avenue, Building 64, Room 3067, Silver Spring, MD 20903. The North American Industrial Classification System (NAICS) code is 541712, and the small business size standard is 500 employees. This procurement is a small business set-aside, thus allowing only small businesses to respond to this notice of intent. It is anticipated that award will be made on or about May 3, 2013. This notice of intent is not a request for competitive quotes. However, all responsible sources may submit a capability statement, proposal, or quotation within seven (7) days after the publication of this synopsis which shall be considered by the agency. Responses received after 7 days or without the required information may not be considered. A determination by the Government not to compete as a result of information received is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. All correspondence submitted in response to this notice shall include the FDA solicitation number in the subject line via email to Ms. Joy Garnett, Contract Specialist. For information concerning this acquisition, contact Ms. Garnett at Joy.Garnett@fda.hhs.gov.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/FDA-13-SOL-113656/listing.html)
- Place of Performance
- Address: 10903 New Hampshire Avenue, Silver Spring, Maryland, 20903, United States
- Zip Code: 20903
- Zip Code: 20903
- Record
- SN03046310-W 20130427/130425235222-142cde2dfac96755bc44aa970b96ea8d (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |